The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Poor performance status and front-line pembrolizumab in advanced non-small-cell lung cancer (NSCLC) patients with PD-L1>50%.
 
Alfredo Addeo
No Relationships to Disclose
 
Giulio Metro
Consulting or Advisory Role - Boehringer Ingelheim
 
Diego Signorelli
No Relationships to Disclose
 
Panagiota Economopoulou
No Relationships to Disclose
 
Fausto Roila
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Ipsen (Inst); MSD Oncology (Inst); Novartis (Inst); Roche (Inst)
 
Giuseppe Luigi Banna
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Janssen-Cilag; Roche
Patents, Royalties, Other Intellectual Property - "Deep Learning Motion Algorithm for Lung Cancer Early Detection in Embedded Systems" with ST Microelectronics; "Image processing method, corresponding system and computer program product" with ST Microelectronics
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb; Ipsen; Pierre Fabre
 
Alessandro De Toma
No Relationships to Disclose
 
Andrea Camerini
No Relationships to Disclose
 
Athina Christopoulou
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Pfizer; Roche; Sanofi
 
Giuseppe Lo Russo
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Lilly; MSD
 
Domenico Galetta
No Relationships to Disclose
 
Beatriz Jimenez Munarriz
No Relationships to Disclose
 
Ana Collazo
No Relationships to Disclose
 
Antonio Calles
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche
 
Panagiotis Baxevanos
No Relationships to Disclose
 
Helena Linardou
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; Novartis; Roche
 
Paris A. Kosmidis
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis; Pfizer
 
Giannis Socrates Mountzios
Honoraria - AstraZeneca; Boehringer Ingelheim; MSD; Roche
Consulting or Advisory Role - AstraZeneca; MSD; Roche
 
Marina Chiara Garassino
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb; GlaxoSmithKline; MSD Oncology; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Incyte; Inivata; Lilly; MSD; Novartis; Pfizer; Roche; Sanofi; Seagen; Takeda; Tiziana Life Sciences
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Celgene; Incyte; Lilly; MSD Oncology; Otsuka; Roche; Takeda
Research Funding - AstraZeneca (Inst); AstraZeneca/MedImmune (Inst); Blueprint Medicines; Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Lilly (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Spectrum Pharmaceuticals (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
 
Alex Friedlaender
Honoraria - Astellas Oncology; Bristol-Myers Squibb; Pfizer; Roche